DISCUSSION Cholesterol levels, as assessed before randomization, were negatively
related to physical aggression during the 4-week baseline period. There was also a …

Objective: Although continuing antidepressant treatment after patients have responded to
medication has been shown to greatly reduce the risk of relapse, this risk is not eliminated. A …

OBJECTIVE: Although the newer antidepressants are widely used, little is known about how
long it takes to see their full effect. The authors sought to determine how many weeks a …

Background: Despite the frequent use of selective serotonin reuptake inhibitors in patients
with coronary heart disease (CHD), their effects on plasma lipid levels have not been …

The serotonin syndrome is a serious and potentially life-threatening adverse event most
often occurring as a result of concomitant treatment with at least two drugs that increase …

Clinically significant antagonistic interactions of the serotonin reuptake inhibitor (SRI)
fluoxetine with the metabolic clearance of other drugs are well Known. 1-4 They include …

We read with great interest a recent report of 2 patients with generalized social anxiety
disorder (SAD) who were successfully treated with duloxetine. 1 The report provided a new …

DISCUSSION Cholesterol levels, as assessed before randomization, were negatively
related to physical aggression during the 4-week baseline period. There was also a …

Background: A simple, once-weekly dosing regimen could be a convenient alternative for
many patients during long-term treatment of depression. Such a strategy might also be …

Background: This study was conducted to determine if patients with major depressive
disorder who had previously failed treatment with one serotonin selective reuptake inhibitor …